Parkinson’s Disease Drives Progressive, Region-Specific Changes in Brain Blood Vessels: New Research Unveils Vascular Role in Disease Progression

Parkinson’s disease causes significant, progressive changes in the brain’s blood vessels, altering traditional understanding of the disease and opening new avenues for potential treatments, according to a recent study by Australian researchers. The study highlights that beyond the well-known accumulation of alpha-synuclein proteins and neuronal loss, region-specific vascular changes contribute critically to disease progression, suggesting the blood vessels’ health in the brain plays a more expansive role than previously recognized.

Key Findings on Brain Blood Vessel Changes

This groundbreaking research, conducted by Neuroscience Research Australia (NeuRA) along with University of New South Wales and University of Sydney collaborators, found increased numbers of string vessels—non-functional remnants of capillaries—in specific brain regions affected by Parkinson’s disease. These changes implicate the cerebrovasculature, including altered blood flow and disrupted blood-brain barrier function, as key factors underlying the disease’s progression. Region-specific vascular alterations appear to parallel and potentially exacerbate the known pathological hallmarks of Parkinson’s.​

Derya Dik, a postdoctoral researcher at NeuRA involved in the study, emphasized the shift in perspective: “Traditionally, Parkinson’s research has concentrated on protein accumulation and neuronal loss but our findings demonstrate significant impacts on cerebrovascular health.” The research underlines the progressive nature of these vascular changes and their location specificity within the brain, providing a refined map of Parkinson’s pathology that could lead to new therapeutic targets.​

Expert Perspectives and Context

Experts not involved in the study recognize the importance of these findings. Dr. Lynsey Bilsland, Managing Director of the Parkinson’s Virtual Biotech, noted that understanding the vascular component adds a valuable dimension to Parkinson’s research and may pave the way for treatments aimed at vascular repair or protection in addition to neuronal preservation. The inclusion of blood vessel health in disease management could complement ongoing efforts like prasinezumab and cell replacement therapies targeting alpha-synuclein pathology and dopaminergic neuron loss.​

The study’s findings align with previous research indicating the blood-brain barrier’s increased permeability in Parkinson’s, particularly in affected regions like the substantia nigra. Vascular dysfunction, including small vessel disease, has been implicated in worsening motor function and cognition, suggesting a synergistic relationship between vascular health and neurodegeneration.

Implications for Public Health and Patients

For the public and patients affected by Parkinson’s, these findings represent hope for future treatments that can slow disease progression by targeting blood vessel changes. Such therapies might improve neurological outcomes by maintaining better blood flow and barrier integrity in the brain, potentially delaying symptoms and preserving function longer.

It emphasizes the importance of cardiovascular health management in Parkinson’s patients, as vascular factors may influence disease severity. Lifestyle measures promoting vascular well-being—such as controlling hypertension, diabetes, and cholesterol, along with regular exercise—could gain renewed focus as part of comprehensive Parkinson’s care.

Limitations and Further Research

While promising, the study acknowledges limitations including the need for larger sample sizes and more longitudinal data to fully understand how vascular changes interact with other disease mechanisms over time. Moreover, it remains to be determined whether similar vascular alterations are present in other neurodegenerative disorders like Alzheimer’s disease and dementia with Lewy bodies, which the research team is actively investigating.​

These findings call for broader investigation into cerebrovascular factors in neurodegeneration and highlight the potential for cross-disease therapeutic strategies. They also underscore the complexity of Parkinson’s disease beyond its classic symptoms and pathology, encouraging a multifactorial approach to research and treatment.

References